Navíc aripiprazol a dehydro- aripiprazol in vitro neprokázal schopnost ovlivnit metabolizmus zprostředkovávaný CYP1A2.
Additionally, aripiprazole and dehydro-aripiprazole did not show potential for altering CYP1A2-mediated metabolism in vitro.